Detailed information for compound 1596535

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 420.63 | Formula: C28H40N2O
  • H donors: 0 H acceptors: 0 LogP: 5.59 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 1
  • SMILES: COCCC[C@@H](N1CCC[C@@H]1C)c1ccc(cc1)c1ccc(cc1)CN1CCCCC1
  • InChi: 1S/C28H40N2O/c1-23-8-6-20-30(23)28(9-7-21-31-2)27-16-14-26(15-17-27)25-12-10-24(11-13-25)22-29-18-4-3-5-19-29/h10-17,23,28H,3-9,18-22H2,1-2H3/t23-,28+/m0/s1
  • InChiKey: KBAMVQCVXIVXJD-NEKDWFFYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens histamine receptor H4 Starlite/ChEMBL References
Rattus norvegicus Histamine H3 receptor Starlite/ChEMBL References
Homo sapiens histamine receptor H3 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Loa Loa (eye worm) hypothetical protein Histamine H3 receptor   445 aa 384 aa 22.4 %
Echinococcus granulosus biogenic amine 5HT receptor Histamine H3 receptor   445 aa 405 aa 25.2 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Loa Loa (eye worm) glycosyl hydrolase family 2 0.0712 0.8835 1
Loa Loa (eye worm) beta-glucuronidase 0.0691 0.8155 0.9231
Entamoeba histolytica beta-galactosidase, putative 0.0504 0.1845 0.5
Trichomonas vaginalis beta-galactosidase, putative 0.0746 1 0.5
Brugia malayi Glycosyl hydrolases family 2, sugar binding domain containing protein 0.0712 0.8835 1
Trichomonas vaginalis conserved hypothetical protein 0.0746 1 0.5

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) Antagonist activity at histamine H1 receptor in guinea pig longitudinally mounted ileum assessed as changes in rate of spontaneous beating up to 10 uM by cardiotachograph analysis ChEMBL. 22222138
Activity (functional) Antagonist activity at histamine H2 receptor in guinea pig longitudinally mounted ileum assessed as changes in rate of spontaneous beating at 1 uM by cardiotachograph analysis ChEMBL. 22222138
Ki (binding) <= 4.5 Displacement of [3H]histamine from human histamine H4 receptor expressed in GPCR97 transfected human SK-N-MC cells ChEMBL. 22222138
Ki (binding) = 8.7 Displacement of [3H]RAMHA from human histamine H3 receptor expressed in GPCR97 transfected human SK-N-MC cells ChEMBL. 22222138
Ki (binding) = 8.83 Displacement of [3H]RAMHA from rat histamine H3 receptor in rat cerebral cortex membranes ChEMBL. 22222138
pKb (functional) = 9.64 Antagonist activity at human histamine H3 receptor expressed in human SK-N-MC cells assessed as inhibition of (R)-alpha-methylhistamine-induced effect after 6 hrs by beta-galactosidase reporter gene assay ChEMBL. 22222138

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.